Industry Research by Koncept Analytics
Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook ----------------------------------------(2017-2021) May 2017
Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)
1
Executive Summary HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person cannot get rid of this virus properly but its effects can be reduced with the treatment. HIV does not get spread easily into human. Only certain body fluids of an infected person can transmit HIV into others. HIV never gets transmitted through casual contacts like handshakes, sharing food or water. It has certain transmission ways including blood transmission of an infected person to non-infected person, exchange of body fluids like semen, pre-seminal or vaginal fluids during unprotected physical contacts and from a mother to child during pregnancy or breastfeeding. HIV therapeutics market is likely to witness a growth with increasing demand for single tablet regimens and growth of HIV diagnostic market is expected to be driven by increasing technological advancements in diagnosis tests. Middle East and Africa are the major contributors to the global HIV market supported by increased prevalence of HIV due to rising drug abuse and unprotected physical contacts among adolescents. AsiaPacific is likely to experience further growth of HIV market due to recent development in HIV treatments. The global HIV market is expected to grow in future due to decreasing HIV related death rates, low awareness of HIV transmission and government initiatives to promote HIV treatment. Key trends of this market include progressing HIV drug under pipeline, increasing adoption of STR and Development of technologically advanced diagnostic products. However, there are some factors which can hinder growth of the market including decreasing global HIV funds, social stigma and discrimination and treatment failures. The report “Global HIV Market: Industry Analysis & Outlook (2017-2021)� by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S along with the global market. The report profiles players of the market including Johnson & Johnson, Merck and Co., Gilead and GlaxoSmithKline Plc. Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)
2
Global HIV therapeutics market is likely to grow with the rising awareness of HIV treatments and increasing demand for single tablet regimens… Global HIV Therapeutics Market Forecast by Value (20162021)
Global HIV Therapeutics Market by Drug Class (2016)
•
Global HIV therapeutics market is expected to reach US$.. billion in 2021, increasing from US$.. billion in 2016, recording growth at a CAGR of ..%.
•
In 2016, integrase inhibitor held a share of ..% of the global HIV therapeutics market followed by NNRTI with a share of ..%.
•
In 2016, the global integrase inhibitor market reached US$.. billion and is expected to reach US$.. billion in 2021, growing at a CAGR of %.
Global Integrase Inhibitor Market Forecast by Value (2016-2021)
Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)
3
Global HIV diagnostic market growth is likely to be driven by rising technological advancements in diagnostic tests… Global HIV Diagnostic Market Forecast by Value (2016-2021)
Global HIV Diagnostic Market by Type (2016)
•
By the year 2021, global HIV diagnostic market is expected to reach US$.. million increasing from US$.. million in 2016, at a CAGR of ..%.
•
In 2016, CD4 tests held a share of ..% of the global HIV diagnostic market followed by viral load tests holding a share of ..%.
•
In 2021, global HIV patient population is expected to reach ..million people increasing from ..million people in 2017, at a CAGR of ..%.
Global HIV Patient Population Forecast (2017-2021)
Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com
Global Human Immunodeficiency Virus (HIV) Market: Industry Analysis & Outlook (2017-2021)
5